NeuBase Therapeutics Price on April 13, 2023

NeuBase Therapeutics Valuation on April 13, 2023

NeuBase Therapeutics Trading Date Momentum on April 13, 2023

On April 14 2023 NeuBase Therapeutics was traded for  3.36  at the closing time. The top price for the day was 3.36  and the lowest listed price was  3.36 . The trading volume for the day was 7.2 K. The trading history from April 14, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.88% . The trading delta at closing time against the current closing price is 95.58% .

NeuBase Therapeutics Fundamentals Correlations and Trends

By evaluating NeuBase Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NeuBase Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NeuBase financial account trend analysis is a perfect complement when working with valuation or volatility modules.

NeuBase Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeuBase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeuBase Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeuBase Therapeutics stock prices may prove useful in developing a viable investing in NeuBase Therapeutics

NeuBase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for NeuBase Therapeutics' price direction in advance. Along with the technical and fundamental analysis of NeuBase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeuBase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.